Imagine a star powered not by nuclear fusion, but by one of the universe’s greatest mysteries—dark matter. Scientists have ...

Bioo CEO Pablo Vidarte says his bioluminescent landscaping will arrive in Dubai within months, following successful ...

RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, today announced its selection to join Lilly Gateway Labs (LGL) in San Diego, an innovation ...

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

A Big Pharma lobbying group has said it backs the MAHA agenda amid a leak suggesting it opposed Robert F. Kennedy Jr.

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns.

The annual Biotechnology Innovation Organization trade show is expected to bring about 20,000 participants to Boston starting on Monday. Here are the expected key topics of discussion.

The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23.8%.Request free copy of this report: 01, 2025 - Integration of AI and ...

Artelo gets Buy rating from Boral Capital after positive updates on ART27.13, ART26.12, and preclinical success of its candidate for depression.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development.